Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com   SPECIAL REPORT #14     Bad News for Alzheimer’s Patients       Within two days, the biopharmaceutical industry had to cope with two setbacks for the treatment of Alzheimer’s disease.   On March 21, Biogen and partner Eisai announced the failure of the […]

  Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #13     News in the Oncology Field       The US FDA has approved the combination of Roche’s Tecentriq with Celgene Abraxane as a treatment for patients with triple-negative breast cancer (TNBC) whose tumors express the PD-L1 protein. This approval […]

      SPECIAL REPORT #12     The US FDA Commissioner Scott Gottlieb resign from his post on 5 March, effective one month from today.     The resignation of Scott Gottlieb took Capitol Hill and the biopharmaceutical industry by surprise as he had pushed back earlier speculation about him leaving the agency. Under […]

      Btobioinnovation.com   Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com   SPECIAL REPORT #11     Drug Pricing in America:  Outcomes of the Senate Finance Committee       For many years the issue of US pricing has been an topic of vigorous debate. In January 2016, at his first press conference after […]

      Btobioinnovation.com     Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com   SPECIAL REPORT #10   Investments in China Healthcare         There is not a single report on global Healthcare which does not mention the impressive outcomes obtained by China over the last decade. Thanks to a a recent State […]

    Btobioinnovation.com     Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #9   European Pharma R&D focus on Specialty Care     In an article published in the May 2018 issue of MedNous entitled  “European pharma plans new strategies for R&D” we wrote “It will be some months before the […]

    Btobioinnovation.com       Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #7   Neuroscience: the poor cousin of drug discovery     This article was published in a slightly revised form in the February 2019 issue of MedNous     Aging populations everywhere are on the rise creating a […]